Sudarshan Pharma Industries Share Price Today | Stock Price & Sudarshan Pharma Industries Share Screener
Track the current Sudarshan Pharma Industries share price and stock price live with TickJournal's free stock screener. Check SUDARSHAN price range for the annual price range and momentum. Use the Sudarshan Pharma Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sudarshan Pharma Industries opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹176 and net income of ₹6, with EBITDA of ₹17, an operating margin of 9.0% and a profit margin of 3.4%.
Sudarshan Pharma Industries Share Price Chart
Track the current stock price of Sudarshan Pharma Industries with an interactive chart. Analyse SUDARSHAN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sudarshan Pharma Industries stock quote in one place.
Sudarshan Pharma Industries Company Profile - Fundamental Screener
Screen Sudarshan Pharma Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SUDARSHAN shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Chemicals sector and the Dyes & Pigments industry, and it trades under ISIN INE00TV01023.
Company Details
Classification
Identifiers and Leadership
Sudarshan Pharma Industries Balance Sheet Screener
Screen SUDARSHAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹642, up from ₹402 in 2025.
Latest statistics put total assets at ₹642 and shareholder funds at ₹155, with a leverage ratio of 1.13.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Assets |
|||||||
| Total Assets | 642 | 402 | 283 | 233 | 138 | 99 | 58 |
| Current Assets | 490 | 335 | 242 | 199 | 130 | 88 | 47 |
| Fixed Assets | 102 | 24 | 26 | 20 | 7 | 6 | 6 |
Liabilities |
|||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 29 | 11 | 11 | 13 | 5 | 6 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||
| Total Equity | 155 | 132 | 112 | 101 | 30 | 23 | 20 |
| Share Capital | 24 | 24 | 24 | 24 | 10 | 10 | 10 |
| Reserves & Surplus | 131 | 104 | 88 | 77 | 20 | 13 | 10 |
Sudarshan Pharma Industries Income Statement Screener - Profit & Revenue Analysis
Screen Sudarshan Pharma Industries income statement and profit fundamentals. Analyze SUDARSHAN quarterly results. Sudarshan Pharma Industries reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹176 and net profit was ₹6, equal to earnings per unit of ₹0.23, at an operating margin of 9%.
In that period expenses were ₹159, interest cost ₹8 and tax ₹2. The next period listed, 2026-Mar, shows revenue of ₹225 and net profit of ₹11.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||||
| Revenue | 176 | 225 | 170 | 171 | 147 | 162 | 116 | 129 | 100 | 232 |
| Expenses | 159 | 201 | 157 | 160 | 134 | 147 | 108 | 117 | 97 | 217 |
Operating Costs and Margins | ||||||||||
| EBITDA | 17 | 24 | 12 | 11 | 12 | 15 | 9 | 12 | 3 | 15 |
| Operating Profit % | 9.00% | 9.00% | 6.00% | 5.00% | 8.00% | 9.00% | 7.00% | 9.00% | 2.00% | 6.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 8 | 8 | 6 | 6 | 6 | 4 | 4 | 4 | 4 | 6 |
Profit and Earnings | ||||||||||
| Profit Before Tax | 8 | 16 | 5 | 4 | 5 | 10 | 4 | 8 | -2 | 9 |
| Tax | 2 | 4 | 1 | 0 | 1 | 3 | 1 | 2 | 0 | 2 |
| Net Profit | 6 | 11 | 4 | 4 | 4 | 7 | 3 | 6 | -1 | 7 |
| EPS | 0.23 | 0.48 | 0.18 | 0.16 | 0.16 | 0.29 | 0.12 | 0.24 | -0.05 | 0.27 |
Sudarshan Pharma Industries Cash Flow Screener - Liquidity Fundamentals
Screen SUDARSHAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹35.
Over the same period, investing activities used ₹20 and financing activities used ₹14.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||
| Operating Activities | 35 | 6 | -29 | -4 | 3 | 1 |
| Investing Activities | -20 | -6 | -26 | -2 | -1 | -3 |
Financing and Net Cash | ||||||
| Financing Activities | -14 | -12 | 66 | 4 | -2 | 0 |
| Net Cash Flow | 0 | -12 | 12 | -1 | 0 | -2 |
Sudarshan Pharma Industries Shareholding Pattern Screener
See Sudarshan Pharma Industries shareholding pattern with promoter, FII, and DII holdings. Check Sudarshan Pharma Industries promoter holding and ownership changes for SUDARSHAN on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Aug, promoters held 58.93%, foreign institutions 0.00%, domestic institutions 0.00% and the public 17.27%, spread across 1,217 shareholders.
The shareholder count was 1,217 in 2026-Aug, compared with 1,231 in 2026-Jun.
| Item | 2026-Aug | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 58.93% | 58.93% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 19.38% | 19.95% | 19.78% | 20.79% | 19.48% | 18.45% | 13.07% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.00% | 0.00% |
| Public Holding | 17.27% | 16.37% | 16.41% | 16.88% | 16.30% | 17.14% | 18.18% | 23.20% |
| Other Holding | 23.75% | 5.27% | 6.20% | 5.90% | 5.46% | 5.94% | 5.98% | 6.33% |
| Shareholder Count | 1,217 | 1,231 | 1,346 | 1,407 | 1,383 | 1,327 | 1,212 | 787 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sudarshan Pharma Industries. Sudarshan Pharma Industries dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.30 | 4.05% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Sudarshan Pharma Industries Stock Index Membership - Nifty & Sensex
See which indices include Sudarshan Pharma Industries stock. Check SUDARSHAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Sudarshan Pharma Industries Market Events Screener - Corporate Actions
Get Sudarshan Pharma Industries corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sudarshan Pharma Industries stock events that may affect SUDARSHAN share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 22, 2026, with a record date of September 22, 2026.
It is followed by Quarterly Result Announcement dated August 12, 2026 and Quarterly Result Announcement dated April 30, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-22 | 2026-09-22 | Annual General Meeting | NA | 0.18% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | -0.26% |
| 2026-04-30 | 2026-04-30 | Quarterly Result Announcement | NA | -0.96% |
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | -0.93% |
| 2025-10-18 | 2025-10-18 | Quarterly Result Announcement | NA | -2.36% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 0.00% |
| 2025-08-11 | 2025-08-11 | Extraordinary General Meeting | NA | 2.74% |
| 2025-07-25 | 2025-07-25 | Annual General Meeting | NA | -8.80% |
| 2025-06-12 | 2025-06-12 | Extraordinary General Meeting | NA | 4.14% |
| 2025-04-24 | 2025-04-24 | Quarterly Result Announcement | NA | -5.82% |
| 2025-02-04 | 2025-02-04 | Extraordinary General Meeting | NA | -19.06% |
| 2024-11-23 | 2024-11-23 | Split | 1:10 | 4.99% |
| 2024-10-31 | 2024-10-31 | Quarterly Result Announcement | NA | 9.01% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -0.07% |
| 2024-09-30 | 2024-09-30 | Extraordinary General Meeting | NA | 94.52% |
Sudarshan Pharma Industries Competitors Screener - Peer Stocks Comparison
Screen SUDARSHAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sudarshan Chemical Industries | 9,414 | 107.09 | 9,866 | 191.99% | 41 | 48.10 |
| Kiri Industries | 3,542 | 0.60 | 1,016 | 18.81% | 5,567 | 55.19 |
| Bodal Chemicals | 2,418 | 36.97 | 2,054 | 16.92% | 48 | 69.33 |
| Indokem | 1,721 | 753.13 | 172 | -3.58% | 2 | 80.16 |
| Bhageria Industries | 1,649 | 24.70 | 881 | 46.41% | 45 | 70.58 |
| Shree Pushkar Chemicals | 1,558 | 22.34 | 990 | 21.18% | 70 | 51.06 |
| Ultramarine & Pigments | 1,222 | 13.25 | 786 | 11.21% | 81 | 48.71 |
| Sudarshan Pharma Industries | 933 | 38.25 | 703 | 38.51% | 23 | 40.35 |
| Sudarshan Colorants | 886 | 18.98 | 808 | -4.30% | 45 | 48.53 |
| Vipul Organics | 497 | 60.98 | 175 | 7.54% | 7 | 48.00 |
Sudarshan Pharma Industries Company Announcements - News & Reports Screener
Screen SUDARSHAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 5, 2026.
The next most recent announcements are dated September 29, 2026 and September 29, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-05 | Announcement under Regulation 30 (LODR)-Diversification / Disinvestment | - |
| 2026-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-29 | Proceedings Of Annual General Meeting Held On 22/SEPT/2026 | - |
| 2026-09-15 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-09-09 | Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-09-09 | Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-29 | Reg. 34 (1) Annual Report. | - |
| 2026-08-29 | Reg. 34 (1) Annual Report. | - |
| 2026-08-29 | Annual General Meeting Of The Company On Tuesday 22/September/2026 | - |
| 2026-08-26 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-08-22 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-08-19 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-17 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-08-14 | FCCB Committee Meeting On Wednesday 19-August-2026 | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
Frequently Asked Questions
How is the company valued right now?
The P/E ratio is 38.25 and the P/B ratio is 5.60, with earnings per unit of ₹0.97. Market capitalisation stands at ₹933.03 Cr. The company operates in the Chemicals sector, in the Dyes & Pigments industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 7 balance sheet periods, 10 income statement periods, 6 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.